Stoke Therapeutics Inc.
STOK | NASDAQ
$28.70
+$0.65 (+2.32%)
Sep 22, 2026, 11:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.33M | 6.23M | 1.4M | 10.63M | 13.82M | 158.57M | 22.61M | 4.89M | 4.83M | 4.22M | 2.8M | 3.31M | -2.48M | 5.15M | 3.27M | 2.91M | 3.23M | 3M | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.14M | 1.05M | 1.06M | 989K | n/a | n/a | n/a | n/a | 1.11M | 1.11M | 1.22M | 1.2M | 1.17M | 1.15M | 1.15M | 924K | 835K | 624K | n/a | n/a | n/a | n/a |
Gross Profit | 8.19M | 5.18M | 347K | 9.64M | 13.82M | 158.57M | 22.61M | 4.89M | 3.72M | 3.1M | 1.59M | 2.11M | -3.65M | 4.01M | 2.12M | 1.98M | 2.4M | 2.38M | n/a | n/a | n/a | n/a |
Operating Income | -65.43M | -53.42M | -61.44M | -43.09M | -27.3M | 111.24M | -13.65M | -30M | -29.34M | -28.37M | -29.59M | -27.23M | -33.26M | -24.69M | -27.18M | -27.15M | -25.24M | -24.8M | -24.53M | -22.68M | -22.03M | -16.83M |
Interest Income | 3.52M | 3.42M | 3.62M | 3.47M | 3.79M | 2.89M | 2.97M | 3.55M | 3.7M | 2.43M | 2.59M | 2.65M | 2.57M | 2.1M | 1.48M | 995K | 544K | 104K | 36K | 44K | 34K | 18K |
Pretax Income | -61.62M | -50M | -57.93M | -39.63M | -23.48M | 114.16M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M | -16.79M |
Net Income | -61.62M | -50M | -57.93M | -38.35M | -23.48M | 112.88M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M | -16.79M |
Selling & General & Admin | 24.57M | 19.97M | 20.5M | 15.48M | 15.26M | 14.65M | 12.84M | 12.69M | 12.48M | 9.67M | 10.02M | 9.71M | 9.67M | 9.66M | 8.84M | 9.41M | 9.58M | 9.11M | 8.72M | 8.32M | 7.93M | 6.91M |
Research & Development | 49.04M | 39.67M | 41.29M | 37.25M | 25.86M | 32.68M | 23.42M | 22.21M | 20.59M | 21.81M | 21.15M | 19.63M | 19.94M | 19.03M | 20.45M | 19.72M | 18.06M | 18.06M | 15.8M | 14.36M | 14.1M | 9.91M |
Other Expenses | n/a | -1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1 | n/a | n/a |
Operating Expenses | 73.62M | 58.6M | 61.79M | 52.73M | 41.12M | 47.33M | 36.27M | 34.9M | 33.06M | 31.48M | 31.17M | 29.34M | 29.61M | 28.7M | 29.29M | 29.13M | 27.63M | 27.17M | 24.53M | 22.68M | 22.03M | 16.83M |
Interest Expense | 17K | 23K | 3K | 3K | 3K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -562K | -550K | -591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 74.75M | 59.65M | 62.84M | 53.72M | 41.12M | 47.33M | 36.27M | 34.9M | 34.17M | 32.59M | 32.39M | 30.54M | 30.78M | 29.84M | 30.44M | 30.05M | 28.47M | 27.8M | 24.53M | 22.68M | 22.03M | 16.83M |
Income Tax Expense | n/a | n/a | n/a | -1.28M | n/a | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 66.02M | 63.06M | 58.39M | 58.61M | 58.35M | 57.86M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
Shares Outstanding (Diluted) | 66.02M | 63.06M | 58.39M | 58.61M | 58.35M | 59.4M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
EPS (Basic) | -0.93 | -0.79 | -0.99 | -0.65 | -0.40 | 1.95 | -0.18 | -0.47 | -0.46 | -0.57 | -0.60 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.60 | -0.46 |
EPS (Diluted) | -0.93 | -0.79 | -0.99 | -0.65 | -0.40 | 1.90 | -0.18 | -0.47 | -0.46 | -0.57 | -0.60 | -0.55 | -0.69 | -0.43 | -0.56 | -0.61 | -0.59 | -0.65 | -0.66 | -0.61 | -0.60 | -0.46 |
EBITDA | -64.29M | -45.56M | -56.88M | -38.63M | -23.04M | 114.63M | -9.96M | -25.89M | -25.15M | -25.81M | -26.33M | -23.34M | -29.49M | -21.4M | -24.5M | -25.19M | -23.82M | -24.03M | -24.21M | -22.34M | -21.72M | -16.59M |
EBIT | -65.43M | -46.61M | -57.93M | -39.62M | -23.48M | 114.16M | -10.48M | -26.43M | -25.7M | -26.37M | -26.96M | -24.54M | -30.65M | -22.55M | -25.66M | -26.11M | -24.65M | -24.65M | -24.45M | -22.6M | -21.97M | -16.83M |
Depreciation & Amortization | 1.14M | 1.05M | 1.06M | 989K | 446K | 477K | 526K | 540K | 548K | 563K | 624K | 1.2M | 1.17M | 1.15M | 1.15M | 924K | 835K | 624K | 235K | 254K | 249K | 236K |
Add to Watchlist
Select watchlists to add or remove STOK